Primary Site >> Colorectal Cancer

Gene >> DDX3X

  • 1995
  • 1996
  • 2011
  • 2015
  • 2016
  • 2017
Ref: Direct measurement of intratumor dose-rate distributions in experimental xenografts treated with 90Y-labeled radioimmunotherapy.
PMID: 7721611
Ref: Effect of pre-irradiation on radiopharmaceutical localization in human colon tumor xenografts using mono- and bispecific monoclonal antibodies.
PMID: 9042206
Ref: Proteomic analysis identifies translationally controlled tumor protein as a mediator of phosphatase of regenerating liver-3-promoted proliferation, migration and invasion in human colon cancer cells.
PMID: 22340241
Ref: DDX3 as a strongest prognosis marker and its downregulation promotes metastasis in colorectal cancer.
PMID: 26087195
Ref: Identification of the DEAD box RNA helicase DDX3 as a therapeutic target in colorectal cancer.
PMID: 26311743
Ref: DDX3 promotes tumor invasion in colorectal cancer via the CK1epsilon/Dvl2 axis.
PMID: 26892600
Ref: DDX3 enhances oncogenic KRASinduced tumor invasion in colorectal cancer via the betacatenin/ZEB1 axis.
PMID: 27007150
Ref: Multifunctional DDX3: dual roles in various cancer development and its related signaling pathways.
PMID: 27186411
Ref: Nucleic acid sensing pattern recognition receptors in the development of colorectal cancer and colitis.
PMID: 28224203
Ref: The YAP1/SIX2 axis is required for DDX3-mediated tumor aggressiveness and cetuximab resistance in KRAS-wild-type colorectal cancer.
PMID: 28435452
Ref: Nuclear DDX3 expression predicts poor outcome in colorectal and breast cancer.
PMID: 28761359
Ref: Role of DDX3 in the pathogenesis of inflammatory bowel disease.
PMID: 29383159